SCHEMBL23504523

SCHEMBL23504523

c1ccc(-c2c3ccccc3c(-c3cccc(-c4ccc(-c5ccc6oc7ccccc7c6c5)c5c4oc4ccccc45)c3)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.45
▸ PLA2G2A P14555 5/20 0.40
▸ PLA2G4A P47712 5/20 0.40
▸ PLA2G10 O15496 1/20 0.40
▸ CDC14B O60729 2/20 0.40
▸ CDC14A Q9UNH5 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GGPS1 O95749 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ PTGES2 Q9H7Z7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504721 1.00 ALOX5 (0.45) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504687 0.95 CDC14B (0.44) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504689 0.95 CDC14B (0.44) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504649 0.94 ALOX5 (0.44) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504708 0.94 PLA2G2A (0.42) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504521 0.92 ALOX5 (0.45) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504522 0.92 ALOX5 (0.45) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL18382842 0.92 ALOX5 (0.44) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL20340590 0.92 ALOX5 (0.41) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL23504476 0.91 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APLA2G10CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038123-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2021-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038123-B2 Compound and organic electronic device using the same CHRM1, CHRM2, C1S ALOX5 3207/4885PLA2G2A 2196/4885PLA2G4A 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback